Maypro has obtained exclusive U.S. distribution rights to Cannabid-All, a whole hemp cannabidiolic acid (CBDA) extract produced through a patented process by supplier Extraordinary Extracts, a division of American BioSciences.
 
“American BioSciences has enjoyed a business relationship with Maypro for more than 22 years and in that time we have always been able to count on them to provide us with the highest-quality all-natural ingredients for our finished products,” said Rick Jahnke and Dave Wales, founders and owners of American BioSciences, in a joint statement. “Now, we are extremely happy that we can provide our first-in-class ingredients to Maypro, a company that has an amazing reputation worldwide, for providing the best ingredients available.”
 
CBDA has certain advantages over CBD, according to Maypro, however, its production is difficult and most extraction methods cannot keep CBDA from decarboxylating into CBD. However, using a proprietary extraction method, Cannabid-All maintains all natural CBDA content from plant to extract that preserves more of the hemp plant’s natural, beneficial health properties. According to the company, Cannabid-All has the highest ratio of CBDA/CBD available, contains less than 0.3% THC, and hemp flower constituents including polyphenols and chlorophyll, making it a full spectrum, whole hemp extract. Additionally, it is a free-flowing powder which mixes easily with other powder ingredients.
 
“At Maypro, we look for science-backed ingredients that meet a market need while offering something unique within the category,” said Dennis Alimonti, director of U.S. nutrition at Maypro. “American BioSciences and Extraordinary Extracts took on a saturated hemp and CBD category and created a patented extraction technology to produce a unique, first-in-class ingredient that far surpasses any competition.”